Efficacy and safety of iontophoresis in patients with age-related cataract: a single-center, randomized, double-masked, controlled trial

Zhongshan Ophthalmic Center0 个研究点目标入组 118 人开始时间: 2015年3月19日最近更新: 2020年8月24日

适应症

试验速览

暂无简介。

•1. ?Adults between the ages of 65 and 80 years old
•2.? LOCS III nuclear opalescence score >=3.0 OR cortical cataract score >=3.0 OR posterior subcapsular score >=1.0 bilateral
•3.? Able to commit to the 4-week follow up
•4. ?Able to understand and sign an informed consent

•1.? Types of cataracts other than age-related, including metabolic cataract, drugs and toxic cataract, congenital cataract, etc
•2. ?Any other ocular pathology that may affect visual acuity, such as glaucoma, uveitis and retinopathy, etc
•3.? Patients with inflammation of the ocular surface and the adjacent area
•4.? History of ocular surgery or laser
•5. ?Patients who are blind in one eye
•6. ?Patients with uncontrolled systemic disease, i.e. high blood pressure (Bp > 160/100 mmHg), diabetes mellitus (GLU-AC >8mg/dl), kidney disease, etc

发起方

Zhongshan Ophthalmic Center